fbpx

U.S. Anti-Doping Agency (USADA)

Click here for the Athlete Connect application

USADA logo.

Global DRO logo in whiteSearch Medications & Ingredients

Search
Search
Close this search box.

U.S. Pentathlon Athlete Logan Storie Accepts Sanction for Anti-Doping Rule Violation

USADA announced today that Logan Storie, of Fayetteville, N.C., an athlete in the sport of pentathlon, has accepted a six-year suspension for his second anti-doping rule violation. Storie’s first violation was announced on February 24, 2017, when he received a 15-month suspension from Union Internationale de Pentathlon Moderne (UIPM) after testing positive for androsterone and etiocholanolone.

Storie, 32, tested positive for ostarine (enobosarm) and GW1516 (GW501516), as well as LGD-4033 (ligandrol) and its metabolite di-hydroxy-LGD-4033, as the result of a sample collected out of competition on October 23, 2020. Ostarine and LGD‐4033 are Non-Specified Substances in the class of Anabolic Agents, while GW1516 is a Non-Specified Substance in the class of Hormone and Metabolic Modulators. Each of these substances is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the UPIM Anti-Doping Rules, all of which have adopted the World Anti-Doping Code (the Code) and the World Anti-Doping Agency (WADA) Prohibited List.

Under the rule governing second violations in the 2021 Code, the length of the period of ineligibility for a second violation may be up to double the otherwise applicable sanction, treated as if it were a first violation. Because Storie tested positive for Non-Specified Substances, the period of ineligibility for a first violation would be four years, making the maximum sanction for a second violation eight years. Storie received a reduction from the eight-year sanction for providing substantial assistance.

Storie accepted a six-year period of ineligibility that began on October 23, 2020, the date his positive sample was collected. Because Storie was tested out of competition and has not competed since October 23, 2020, there are no competitive results to disqualify.

In an effort to aid athletes, as well as support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to file and update athlete Whereabouts, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.

In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as an easy-reference wallet card with examples of prohibited and permitted substances, a supplement guide, a nutrition guide, an athlete handbook, and periodic alerts and advisories.

USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by email at playclean@usada.org, by phone at 1-877-Play Clean (1-877-752-9253) or by mail.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.


For more information or media inquiries, click here.